Matt Tripp, PhD


Matthew Tripp, PhD, Vice President of Research and Development. Dr. Tripp received his Ph.D. in microbiology and physiology from the department of Bacteriology and Public Health at Washington State University, Pullman, WA in 1981. He spent the next 5 years in the Department of Biology at the University of California at San Diego, where he conducted biochemical and molecular genetic research directed toward elucidating the molecular mechanisms regulating cellular growth and differentiation. Dr. Tripp was a pioneer in the field of nutrigenomics. He identified novel protein phosphorylation in cells correlated to nutritional signals. He also discovered relationships between phosphorylated proteins and states of cellular proliferation and differentiation, as well as chromosomal morphology. These protein phosphorylation cascades are now known to be central to nutrigenomic signaling as well as diseases, including oncogenesis, inflammation, metabolic syndrome, type 2 diabetes, and cardiovascular disease. In addition to his academic career, Dr. Tripp has been conducting industrial research for over 25 years, 15 of which were in the fortune 100 companies of Miller, General Foods, Kraft, and Kellogg’s. Dr. Tripp has served as Vice President of Research and Development for Metagenics and MetaProteomics since 2000. He holds several biotechnology related patents, and his research has been published in peer-reviewed journals.


What Human Mutations in Kinase Genes May Be Telling Us about Approaches to Personalized Nutrition, Novel Nutritional Therapies, and Mom’s Advice to Eat Your Vegetables